Meeting Banner
Abstract #4357

Diagnostic Activity of a New Targeted Theranostic Agent for the Peri-Infarct Region in Stroke

Jess Agulla1, David Brea1, Barbara Argibay1, Miguel Blanco1, Jos Castillo1, Pedro Ramos-Cabrer1

1Clinical Neuriosciences Research Laboratory, Department of Neurology, University Clinical Hospital, University of Santiago de Compostela, Santiago de Compostela, Spain

In this work we report the development of a theranostic molecule containing Gadolinium based imaging probes, targeted to cells of the peri-infarct region in stroke. The molecular marker used as target for peri-infarct tissue was found by proteomic and immunohistological studies. Fluorescence microscopy and MRI were used to test the diagnostic capacity of the theranostic molecule, allowing the identification of cells of the peri-infarct region.

Keywords

abstract achieved acknowledge activity affected agent agents allowing among analyzed animal antibodies blot bottom brain brains candidates capacity cells cholesterol clinical conducted constructed contrast control core coupled culture damage decay definition designed determined develop development diagnostic entities exponential expressed expressing expression extrusion family film financial fluorescence fraction framework front health healthy heat heating highly histochemical histochemistry hospital hydration identification incubated incubation induction infarct innovation interaction interacts laboratory land lipid male maps marker markers mass material mediators medium microscopy ministry minor model models molecular molecules mono multidisciplinary neurology occlusion page parametric part period permanent probe probes program proper protein proteins proved rats recognition recovery reduced remodeling report resting saturation science selected severely shock specifically spectrometry spreading stained stressed stroke studies suitable support suture system target targeted targeting targets therapeutic tissue tissues transient treatment unaffected unique vitro wester western